| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | 0.095 | 0.01 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.01 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.01 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | 0.14 | 0.02 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.02 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.14 | 0.02 |
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.074 | 0.02 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.02 |